---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-004854"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2022-03-29T23:59:59+00:00"
generated_at: "2026-06-26T15:02:11.205222+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Nkarta appoints manufacturing executive Angela Thedinga to its Board of Directors

## Summary
- Appointed Angela Thedinga as independent Class I director effective March 28, 2022.
- Received stock option for 32,000 shares vesting in three equal annual installments.
- Will receive annual cash retainer of $40,000, pro-rated for Q1 2022.
- Thedinga most recently CTO of Adverum Biotechnologies; previously at AveXis/Novartis Gene Therapies.

## SEC filing metadata
- accession: 0000950170-22-004854
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2022-03-29T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000095017022004854/0000950170-22-004854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000095017022004854/nktx-20220328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-004854
- JSON: https://secwatch.observer/filing/0000950170-22-004854.json
- Plain text: https://secwatch.observer/filing/0000950170-22-004854.txt

## Key facts
- Executive change
  Angela Thedinga was appointed as Director at Nkarta, Inc..
  - Action: appointed
  - Role: Director
  source text: On March 28, 2022, the Board of Directors (the "Board") of Nkarta, Inc. (the "Company"), on the recommendation of the Nominating and Governance Committee of the Board, increased the size of the Board from nine directors to ten directors and appointed Angela Thedinga to the Board effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787400/000095017022004854/0000950170-22-004854-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.